688710
vs
S
Shanghai Composite
688710
Over the past 12 months, Shanghai InnoStar Bio-tech Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +47% compared to the Shanghai Composite's +21% growth.
Stocks Performance
688710 vs Shanghai Composite
Performance Gap
688710 vs Shanghai Composite
Performance By Year
688710 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Shanghai InnoStar Bio-tech Co Ltd
Glance View
Shanghai InnoStar Bio-tech Co Ltd is a China-based company that mainly provides biopharmaceutical non-clinical research services. The Company's services mainly cover early drug development evaluation of biopharmaceuticals, non-clinical research, and clinical testing and translational research. The early drug development evaluation of biopharmaceuticals develops multiple early toxicity rapid prediction and screening models. The clinical testing and translational research business mainly provides analytical methods and data support for the clinical pharmacokinetics, efficacy, and safety research of innovative drug projects. The non-clinical research section specifically includes non-clinical safety evaluation, non-clinical pharmacokinetic research, and non-clinical pharmacodynamic research.
